Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 70

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 70
---
including post-effective amendments) and supplements to such registrations
and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions
as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv)
take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any
jurisdiction where it would not otherwise be required to qualify but for this , (y) subject itself to taxation in any
such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify the
Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the registration
or qualification of any of the Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction
in the United States or its receipt of written notice of the initiation or threatening of any proceeding for such purpose.

| 4 |

e. As
promptly as reasonably practicable after becoming aware of any event or fact, the result of which makes a material fact included in any
Registration Statement, as then in effect, or any prospectus included therein untrue or results in the omission of a material fact required
to be stated therein or necessary in order to make the statements then made therein (in the case of any prospectus, in light of the circumstances
under which they were made) not misleading, the Company shall notify the Investor in writing of the happening of such event or existence
of such facts and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission,
and deliver a copy of such supplement or amendment to the Investor. The Company shall also promptly notify the Investor in writing (i)
when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when any Registration Statement or any
post-effective amendment has become effective (notification of such effectiveness shall be delivered to the Investor by email or facsimile
on the same day of such effectiveness or by overnight mail), (ii) of any request by the SEC for amendments or supplements to any Registration
Statement or related prospectus or related information, and (iii) of the Company’s reasonable determination that a post-effective
amendment to any Registration Statement would be appropriate.

f